| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
1994-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d92823f470bb6eacb7f7f10c1606cb55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b068b70d84d1319a1c8136b6b13f258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7176a88dbca57989e9704edef9dc9fe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e28dc6e877b89cf4849b7bf7c62ae1e |
| publicationDate |
1999-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-RE36187-E |
| titleOfInvention |
Acyclic pyrrolo 2,3-d!pyrimidine analogs as antiviral agents |
| abstract |
This invention relates to the use of acyclic substituted pyrrolo[2,3-d]pyrimidine nucleoside analogs in the treatment of viral infections. Such substituted compounds retain antiviral properties present in their parent compounds, yet exhibit significantly decreased levels of cytotoxicity, thereby having therapeutic potential as antiviral agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6887690-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7262029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007293662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003769-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7433013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005134791-A1 |
| priorityDate |
1988-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |